We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+24.33%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$483M
AUM Growth
+$72.4M
Cap. Flow
-$15.1M
Cap. Flow %
-3.12%
Top 10 Hldgs %
50.46%
Holding
134
New
11
Increased
10
Reduced
44
Closed
10

Top Buys

Rank Stock Value
1
UNM icon
Unum
UNM
+$5.37M
2
MRK icon
Merck
MRK
+$5.25M
3
ETSY icon
Etsy
ETSY
+$40.7K
4
TTWO icon
Take-Two Interactive
TTWO
+$39.2K
5
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$25.9K

Top Sells

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$9.41M
2
MIDD icon
Middleby
MIDD
+$7.74M
3
PXD
Pioneer Natural Resource Co.
PXD
+$3.95M
4
AMD icon
Advanced Micro Devices
AMD
+$1.42M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 29.31%
2 Financials 21.11%
3 Healthcare 18.27%
4 Communication Services 9.22%
5 Consumer Staples 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNM icon
26
Unum
UNM
$14.2B
$5.64M 1.17%
+340,000
New +$5.37M
PG icon
27
Procter & Gamble
PG
$338B
$3.71M 0.77%
31,055
– –
AMAT icon
28
Applied Materials
AMAT
$417B
$2.88M 0.6%
47,580
+375
+0.8% +$20.2K
CVX icon
29
Chevron
CVX
$386B
$2.85M 0.59%
32,000
-12,703
-28% -$1.14M
AFL icon
30
Aflac
AFL
$60.7B
$2.39M 0.49%
66,331
+525
+0.8% +$19K
MSFT icon
31
Microsoft
MSFT
$3.74T
$1.94M 0.4%
9,538
-300
-3% -$54.5K
GILD icon
32
Gilead Sciences
GILD
$168B
$1.65M 0.34%
21,455
– –
ABBV icon
33
AbbVie
ABBV
$442B
$1.58M 0.33%
16,145
– –
VZ icon
34
Verizon
VZ
$196B
$1.47M 0.3%
26,618
– –
VRSN icon
35
VeriSign
VRSN
$26B
$1.24M 0.26%
6,004
-34
-0.6% -$7.06K
MMM icon
36
3M
MMM
$94.4B
$967K 0.2%
7,415
+119
+2% +$15K
DOW icon
37
Dow Inc
DOW
$22.6B
$951K 0.2%
23,321
-5,133
-18% -$188K
RDS.A
38
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$901K 0.19%
27,574
– –
AMGN icon
39
Amgen
AMGN
$224B
$897K 0.19%
3,802
+40
+1% +$9.13K
VRTX icon
40
Vertex Pharmaceuticals
VRTX
$134B
$735K 0.15%
2,533
-5,195
-67% -$1.41M
REGN icon
41
Regeneron Pharmaceuticals
REGN
$82.1B
$733K 0.15%
1,176
-325
-22% -$184K
PFE icon
42
Pfizer
PFE
$152B
$707K 0.15%
22,777
-158
-0.7% -$5.37K
SCHW
43
Charles Schwab
SCHW
$186B
$626K 0.13%
18,557
– –
ABT icon
44
Abbott
ABT
$190B
$591K 0.12%
6,460
– –
KO icon
45
Coca-Cola
KO
$372B
$547K 0.11%
12,230
– –
INTC icon
46
Intel
INTC
$493B
$500K 0.1%
8,355
-400
-5% -$23.9K
XOM icon
47
ExxonMobil
XOM
$657B
$475K 0.1%
10,611
-2,850
-21% -$128K
ROST icon
48
Ross Stores
ROST
$80.8B
$469K 0.1%
5,500
– –
MCD icon
49
McDonald's
MCD
$194B
$456K 0.09%
2,475
– –
AVY icon
50
Avery Dennison
AVY
$13.6B
$434K 0.09%
3,800
– –
1
2
3 4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Kelly Lawrence W & Associates held 134 positions worth $483M, up 18% from $411M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Kelly Lawrence W & Associates withdrew a net $15.1M in Q2 2020, closing 10 positions and reducing 44 holdings. Its most notable exit was D.R. Horton, an estimated $9.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Kelly Lawrence W & Associates opened a new position in Unum worth $5.64M.

  • Kelly Lawrence W & Associates's largest Q2 2020 buy was Unum: 340,000 shares worth $5.64M.
  • Kelly Lawrence W & Associates added most to Merck in Q2 2020, an estimated $5.25M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2020 reduction was Advanced Micro Devices, cutting an estimated $1.42M.
  • Kelly Lawrence W & Associates fully exited D.R. Horton in Q2 2020, selling an estimated $9.41M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 50% of its $483M portfolio in Q2 2020.
  • Kelly Lawrence W & Associates opened 11 new positions and closed 10 in Q2 2020.
  • Kelly Lawrence W & Associates's portfolio value rose 18% quarter-over-quarter to $483M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2020, filed 14 Aug 2020.